2nd oncology beyond the obvious (obto) in-person conference | io in sclc long term follow up data
Published 7 months ago • 62 plays • Length 10:20Download video MP4
Download video MP3
Similar videos
-
1:00:58
2nd oncology beyond the obvious (obto) in-person conference | gynecological cancer
-
7:21
second- & third-line options after chemotherapy or i/o
-
4:32:57
46th icon conference day 1
-
1:18:41
escalate emerging and current landscape in treatment of egfrm nsclc
-
0:16
activated t cell attacks a cancer cell
-
58:19
the implications of recent datasets for the current and future management of nsclc egfr mutations
-
1:04:50
a new era has begun in the treatment of sclc: navigating novel therapeutic options and strategies
-
17:00
emerging approaches to small cell lung cancer | 2022 evolution conference
-
3:02
osimertinib for treating non-small cell lung cancer
-
5:18
nsclc management: second-line options
-
4:44
moderator commentary: immunotherapy in non-small cell lung cancer
-
31:39
lymphoma | 2022 oneoncology conference
-
1:03:14
changing the game for es-sclc with immunotherapy and multidisciplinary collaboration
-
0:39
the patient experience is crucial in developing #lungcancer clinical trials
-
1:41
dr. brahmer discusses second-line pembrolizumab in nsclc
-
4:27
emerging treatment options for sclc
-
1:00:33
immunotherapy in the metastatic settings in non-small cell lung cancer